Lichen planus explained

Lichen planus
Field:Dermatology
Synonyms:LP

Lichen planus (LP) is a chronic inflammatory and autoimmune disease that affects the skin, nails, hair, and mucous membranes.[1] [2] It is not an actual lichen, but is named for its appearance. It is characterized by polygonal, flat-topped, violaceous papules and plaques with overlying, reticulated, fine white scale (Wickham's striae), commonly affecting dorsal hands, flexural wrists and forearms, trunk, anterior lower legs and oral mucosa.[3] The hue may be gray-brown in people with darker skin.[4] Although there is a broad clinical range of LP manifestations, the skin and oral cavity remain as the major sites of involvement.[5] The cause is unknown, but it is thought to be the result of an autoimmune process with an unknown initial trigger. There is no cure, but many different medications and procedures have been used in efforts to control the symptoms.

The term lichenoid reaction (lichenoid eruption or lichenoid lesion) refers to a lesion of similar or identical histopathologic and clinical appearance to lichen planus (i.e., an area which resembles lichen planus, both to the naked eye and under a microscope).[6] [7] Sometimes dental materials or certain medications can cause lichenoid reactions. They can also occur in association with graft versus host disease.[8]

Classification

Lichen planus lesions are so called because of their "lichen-like" appearance[9] and can be classified by the site they involve, or by their morphology.

Site

Lichen planus may be categorized as affecting mucosal or cutaneous surfaces.

Pattern

Lichen planus lesions can occur in many different forms:

Lesion morphologyDescription[15]
PapularPapular form is the classic cutaneous lichen planus (CLP) lesion characterized by shiny, red or purple-colored, flat-topped papule. Lesions may have a thin, transparent, and adherent scale. Fine whitish points or lacy lines (Wickham's striae) may be seen on the surface of well-developed papules.
Annular 'Ring-shaped' lesions that develop gradually from single small pigmented spots into circular groups of papules with clear, unaffected skin in the center. The ring-like lesions may very slowly enlarge, co-join and morph into larger irregular (serpentine) bands, sometimes accompanied by lines (See Linear, below). Annular CLP is uncommon and classically involves the male genitalia (glans penis and penile shaft), groin, axilla and also the extremities.
Linear Papules are arranged in a line (the "Blaschko line").[16] This pattern may develop secondary to trauma (koebnerization) or, uncommonly, as a spontaneous, isolated eruption, usually on the extremities, and rarely on the face.[17]
Hypertrophic This pattern is characterized by hyperkeratotic thick pruritic red-brown to purple-gray plaques with follicular accentuation. Hypertrophic CLP commonly involves the extremities, especially the interphalangeal joints and the anterior legs in a symmetrical distribution. This form is also known as "lichen planus verrucosus".
Atrophic This morphology is characterized by the presence of a few well-demarcated, white-bluish papules or plaques with central superficial atrophy. Atrophic CLP is the clinical endpoint of chronic annular or hypertrophic LP with atrophic lesions. The use of potent topical corticosteroids for a long-term may predispose the patient to developing atrophic lesions.
Bullous This morphology is characterized by the development of vesicles and bullae with the skin lesions. This is a rare variant of lichen planus, and also known as "vesiculobullous lichen planus".
ActinicRare form presenting as nummular patches or plaques with a hypopigmented halo surrounding a hyperpigmented center. Actinic CLP is more prevalent in African Americans, Indians, and Middle-Eastern individuals and commonly affects the sun-exposed areas.
Ulcerative This morphology is characterized by chronic, painful bullae and ulceration of the feet, often with cicatricial sequelae evident. This is a rare variant of lichen planus.
Pigmented This morphology is characterized by hyperpigmented, dark-brown macules in sun-exposed areas and flexural folds. This is a rare variant of lichen planus.
FollicularCharacterized by follicular, flat, elevated or hemispherical erythematous papules with or without keratoses presenting in groups or disseminated. The Graham‐Little‐Piccardi‐Lasseur syndrome, seen in a familial pattern and also predominantly in women, is characterized by the appearance of follicular LP on the trunk with LP follicularis decalvans on the scalp. Follicular LP on the scalp is more likely to lead to scarring alopecia.
InverseCharacterized by extensive erythematous lesions with poorly defined borders and in part with lichenification. Inverse LP typically affects the axillae, inguinal creases, limb flexures and submammary region. Pigmentation of the individual lesions at these inverse locations are typical. Additionally, keratotic papules and erosions with a bizarre configuration can occur.

Overlap syndromes

Occasionally, lichen planus is known to occur with other conditions. For example:

Signs and symptoms

Although lichen planus can present with a variety of lesions, the most common presentation is as a well defined area of purple-coloured, itchy, flat-topped papules with interspersed lacy white lines (Wickham's striae). This description is known as the characteristic "6 Ps" of lichen planus: planar (flat-topped), purple, polygonal, pruritic, papules, and plaques. This rash, after regressing, is likely to leave an area of hyperpigmentation that slowly fades. That said, a variety of other lesions can also occur.

Skin

Variants of cutaneous lichen planus are distinguished based upon the appearance of the lesions and/or their distribution.[21] Lesions can affect the:

Other variants may include:

Mucous membranes

Lichen planus affecting mucosal surfaces may have one lesion or be multifocal.[33] Examples of lichen planus affecting mucosal surfaces include:[33]

Mouth

Oral lichen planus (also termed oral mucosal lichen planus), is a form of mucosal lichen planus, where lichen planus involves the oral mucosa, the lining of the mouth.[39] This may occur in combination with other variants of lichen planus. Six clinical forms of oral lichen planus (OLP) are recognized:[40]

!Lesion morphology!Description
ReticularThe most common presentation of oral lichen planus (OLP) is characterised by the net-like or spider web-like appearance of lacy white lines, known as Wickham's striae.[41] This is usually asymptomatic. Reticular OLP may progress to the more severe subtypes, such as the erosive form, if left untreated.
Erosive/ UlcerativeThe second most common form and the most advance form of oral lichen planus, is characterised by oral ulcers presenting with persistent, irregular areas of redness, ulcerations and erosions covered with a yellow slough. This can occur in one or more areas of the mouth. In 25% of people with erosive oral lichen planus, the gums are involved, described as desquamative gingivitis (a condition not unique to lichen planus). This may be the initial or only sign of the condition.[42] Involvement of the dorsum of the tongue might cause an altered sense of taste (dysgeusia).
PapularThis form is characterized by small white pinpoint papules that are asymptomatic. Hence, they can be easily missed during a routine checkup. It is referred to as the initial and transient phase of OLP.
Plaque-likeLarge, homogenous white patches are characteristic of this form which may resemble leukoplakia. This form is more prevalent in tobacco smokers.
AtrophicThis form is a common presentation that has similarities to the erosive form. It has a more prominent atrophic lesion on a background of erythema with radiating white striae at the margins. Atrophic oral lichen planus may also manifest as desquamative gingivitis.
BullousRare form of OLP characterized by fluid-filled vesicles ranging in size from 1 to 2 mm to several cm in diameter. The vesicles or bullae appear white or gray-purple in color and are fluctuant. The fluid in the vesicles are usually clear but may be hemorrhagic or purulent upon secondary infection. These rupture easily and they leave an ulcerated, painful surface.
These types often coexist in the same individual. Oral lichen planus (OLP) tends to present bilaterally as mostly white lesions on the inner cheek, although any mucosal site in the mouth may be involved. Other sites, in decreasing order of frequency, may include the tongue, lips, gingivae, floor of the mouth, and very rarely, the palate.

Generally, oral lichen planus tends not to cause any discomfort or pain, although some people may experience soreness when eating or drinking acidic or spicy foodstuffs or beverages. When symptoms arise, they are most commonly associated with the atrophic and ulcerative subtypes. These symptoms can include a burning sensation to severe pain. They may also experience mucosal bleeding in response to mild trauma, such as toothbrushing. Additionally, the Koebner phenomenon (the development of new lesions at sites of trauma) is not only present in cutaneous lichen planus (CLP) but can also occur in the setting of OLP.

Residual postinflammatory hyperpigmentation has been reported in association with OLP, manifesting as brown to black pigmentation on the oral mucosa and may most likely occur in dark-skinned individuals.[43]

OLP may occur as a sole manifestation of the disease or in conjunction with other clinical manifestations of LP, including cutaneous LP, genital LP, nail LP, and lichen planopilaris (scalp LP).

Causes

Cutaneous LP is a self-limiting condition. It usually resolves within 6 to 12 months. Oral LP is a non infectious, chronic inflammatory condition that involves the oral mucosa and may be accompanied by skin lesions. The etiology of oral LP are unknown.

It is not clear whether the mechanisms causing isolated oral LP are different from those causing oral LP with cutaneous LP. An immune-mediated mechanism where basal keratinocytes are being targeted as foreign antigens by activated T cells, especially CD8+ T cells, has been proposed.[44] Upregulation of intercellular adhesion molecule-1 (ICAM-1) and cytokines associated with T-helper 1 immune response, may also play an important role in the pathogenesis of lichen planus.

Stress is thought to play a role in the pathogenesis of oral LP. Patients with anxiety and depression are reported more commonly with oral LP if compared to normal healthy individuals.[45] [46] Some studies have indicated that stressful events can induce LP lesions in otherwise healthy individuals. However, a cause effect relationship between stress and the onset of oral LP has not been demonstrated.

Autoimmune response to epithelial self-antigens remains a possibility. A single study of cutaneous LP reported evidence in support of autoimmunity by expanding in vitro T cells isolated from the skin lesions of two patients, followed by testing the ability of these T cells to kill autologous keratinocytes (cytotoxicity).

Several potential triggers of oral LP have been proposed over the years, mainly

  1. Hypersensitivity reaction
    • Restorative material (e.g. amalgam[47] and composite) or drugs can cause hypersensitivity reaction and lead to oral LP.
    • Oral LP usually resolve upon removal of the trigger, as is characteristics of oral LP
  2. Viral infection

Pathogenesis

Oral LP is considered to be a T-cell mediated chronic inflammatory tissue reaction that results in a cytotoxic reaction against epithelial basal cells.[48] The inflammatory infiltrate in oral LP is primarily composed of CD8+ T cells. A potential pathway for CD8+ T cell-mediated cytotoxicity in oral LP is described as follows:

Antigens presented on MHC 1 molecules activates CD8+ T cells on keratinocytes or by encounters with activated CD4+ helper T cells or cytokines produced by activated CD4+ helper T cells

Activated CD8+ T cells induce keratinocyte apoptosis through various mechanisms such as secretion of tumor necrosis factor (TNF)-alpha, secretion of granzyme B, or Fas-Fas ligand interactions. Chemokines are produced by activated CD8+ T cells that attract additional inflammatory cells, thereby promoting continued inflammation.

Other mechanisms that have been proposed include:

Oral LP may also be caused by genetic factor which influence the immune function. A separate study performed in China[52] found an association between a polymorphism in the TNF-alpha gene and risk for oral LP in a subset of patients. An Italian study found a significant increase in a genetic polymorphism of the first intron of the interferon (IFN)-gamma promoter in patients with oral LP compared with controls.[52]

Diagnosis

Skin

Patient history and clinical presentation need to be taken to diagnose lichen planus. Patients with suspected cutaneous lichen planus need to be evaluated clinically through patient interviews and physical examinations. Patients should be questioned about their medication history, any history of pruritus or genital pain and history of dysphagia or odynophagia. Examination of entire cutaneous surface including the scalp, oral cavity and external genitalia need to be included. Wickham's striae often can be seen during microscopic examination of cutaneous lesions of lichen planus.[53] [54]

To confirm the diagnosis of cutaneous lichen planus, a skin biopsy can be done. A punch biopsy of sufficient depth to the mid dermis is usually significant. Immunofluorescence studies are not always needed. Direct immunofluorescence (DIF) can be useful in patients with bullous lesions to differentiate the condition from an autoimmune vesiculobullous disease.

Mouth

A diagnosis of oral lichen planus (LP) is confirmed through review of the patient history, physical examination, and histologic findings.

The clinical evaluation should include a patient history that assesses the following:

A full examination that includes the evaluation of the mucosal and cutaneous surfaces, including the vulva, vagina, penis, scalp, and nails should be performed. Thorough examination may lead to the detection of extraoral manifestations of LP that provide additional support for the diagnosis or the identification of clinical findings that suggest another diagnosis.

Tissue biopsies of oral LP help to confirm the diagnosis and are particularly of value for erythematous and erosive LP, which share features with multiple other mucosal disorders, including oral malignancy. Biopsies to confirm oral LP are less essential in patients who present with classic reticular LP, particularly in patients in whom a diagnosis of LP has already been confirmed through biopsy of an extraoral manifestation of this disorder.[55] [56]

Differential diagnosis

Skin

  1. Lichenoid drug eruption
    • The cutaneous manifestations resemble idiopathic lichen planus.
  2. Chronic graft-versus-host disease
    • The history of preceding hematopoietic cell transplant is helpful for diagnosis
  3. Psoriasis
  4. Atopic dermatitis
  5. Cutaneous lupus erythematosus
  6. Discoid lupus erythematosus

Mouth

Oral lichenoid drug reaction

Lichenoid drug eruptions may be caused by a variety of systemic medications and share clinical features with oral LP. Histologic findings of a deep mixed infiltrate with lymphocytes, plasma cells, and neutrophils (with or without eosinophils) and perivascular inflammation favor this diagnosis.

Oral lichenoid contact reaction (allergic contact mucositis)

Oral lichenoid contact reactions may be caused by a variety of substances. The clinical and histologic features of oral lichenoid contact reactions are similar to oral LP. Patch testing and recognition of the proximity of an offending substance to the eruption can aid with diagnosis.

Autoimmune blistering diseases

Mucous membrane pemphigoid and other autoimmune blistering diseases may present with oral erosions and desquamative gingivitis similar to that seen in erosive LP. Biopsies for routine histologic examination and direct immunofluorescence are useful for distinguishing these disorders from oral LP.

Graft-versus-host disease (GVHD)

Lacy, reticulated plaques or erosions that resemble oral LP may occur in GVHD. The histologic findings of these disorders are also similar. The patient history is useful for differentiating chronic GVHD from oral LP.[57] Oral involvement in acute GVHD is less well characterized than chronic GVHD, but has been associated with erythematous, erosive, ulcerative, or lichenoid oral lesions.

Leukoplakia

Leukoplakia is a manifestation of squamous epithelial hyperplasia that may be a precursor to oral squamous cell carcinoma. White patches or plaques usually appear on the oral mucosa. To rule out malignancy, a biopsy of leukoplakia is indicated.[58]

Oral squamous cell carcinoma

Oral squamous cell carcinoma (SCC) can present as erythematous or white patches, ulcers, or exophytic masses. The highest risk for oral SCC may occur in patients with erythematous or erosive oral LP.[59] [60] [61] A biopsy is indicated.

Leukoedema

Leukoedema is a common, benign finding in the oral cavity that presents as white-gray, somewhat translucent plaques on the mucosa. The buccal mucosa is the most common site for involvement. Symptoms are absent, and no treatment is necessary.[62] [63]

Oropharyngeal candidiasis

Oropharyngeal candidiasis (also known as thrush) is a common infection that has a predilection for infants, older adults with dentures, immunosuppressed individuals, and individuals utilizing intraoral corticosteroid therapy. Patients present with white plaques or erythematous patches on the buccal mucosa, palate, tongue, or oropharynx that may be mistaken for reticular LP.[64]

Histopathology

The histologic findings of oral LP can offer strong support for the diagnosis, but are not pathognomonic. Clinical correlation is required. Common histologic findings of oral LP include:[47]

Nonetheless, interpreting the histopathological features of oral LP has been associated historically with high intra-observer and inter-observer variabilities.[65]

Treatment

There is no cure for lichen planus, and so treatment of cutaneous and oral lichen planus is for symptomatic relief or due to cosmetic concerns.[66] When medical treatment is pursued, first-line treatment typically involves either topical or systemic corticosteroids, and removal of any triggers.[67] Without treatment, most lesions will spontaneously resolve within 6–9 months for cutaneous lesions, and longer for mucosal lesions.[68]

Skin

Many different treatments have been reported for cutaneous lichen planus, however there is a general lack of evidence of efficacy for any treatment.[69] [70] Treatments tend to be prolonged, partially effective and disappointing. The mainstay of localized skin lesions is topical steroids. Additional treatments include retinoids, such as acitretin, or sulfasalazine. Narrow band UVB phototherapy or systemic PUVA therapy are known treatment modalities for generalized disease.[44]

Mouth

Reassurance that the condition is benign, elimination of precipitating factors and improving oral hygiene are considered initial management for symptomatic OLP, and these measures are reported to be useful. Treatment usually involves topical corticosteroids (such as betamethasone, clobetasol, dexamethasone, and triamcinolone) and analgesics, or if these are ineffective and the condition is severe, then systemic corticosteroids may be used. Calcineurin inhibitors (such as pimecrolimus, tacrolimus or cyclosporin) are sometimes used. While topical steroids are widely accepted as first line treatment for mucosal lichen planus, there is only weak evidence to support their effectiveness for erosive oral lichen planus.[71]

Prognosis

Cutaneous lichen planus lesions typically resolve within six months to a year. However, some variant such as the hypertrophic variant might persist for years if left untreated or unmonitored.[2]

It is found that cutaneous lichen planus does not carry a risk of skin cancer.[72] In contrast to cutaneous LP, which is self limited, lichen planus lesions in the mouth may persist for many years, and tend to be difficult to treat, with relapses being common.[2]

Although this condition was first described almost a century ago, it has been reported that its associated oral cancer risk has been exaggerated.[73] Overall, it is found that patients with erythematous or erosive oral lichen planus have a higher risk of oral squamous cell carcinoma compared to patients diagnosed with other variants.[74]

Due to the possibility that oral LP may increase risk for oral cancer, patients with oral lichen planus are encouraged to avoid activities known to increase the risk for oral cancer, such as smoking and alcohol use.

Patients with oral lichen planus should be followed-up at least every 6 to 12 months, to assess the disease activity, changes in symptoms or even detect early signs of malignancy.

Epidemiology

The overall estimated prevalence of lichen planus in worldwide population is in the range of 0.2% to 5%.[75] [76] [77] [78] [79]

It generally occurs more commonly in females, in a ratio of 3:2, and most cases are diagnosed between the ages of 30 and 60, but it can occur at any age.[80]

Lichen planus can occur in patients as diverse cutaneous manifestations alone or in combination with mucosal lichen planus and, or lichen planus of the nails. Study shows that frequency of mucosal involvement of lichen planus patients is 30- 70%.[15]

Oral lichen planus is relatively common, It is one of the most common mucosal diseases. The prevalence in the general population is about 1.27–2.0%, and it occurs more commonly in middle aged people. Oral lichen planus in children is rare. About 50% of females with oral lichen planus were reported to have undiagnosed vulvar lichen planus.

Some studies suggest that cutaneous lichen planus is more commonly found in men whilst oral lichen planus lesions are more commonly found in women.[81] [82] [83] [84] [85] [86]

History

Lichen planus was first described in 1869 by Erasmus Wilson as an inflammatory disorder with unknown etiology. Initially, the characteristic surface markings or striae was described by Weyl in 1885. In 1895, Wickham further explained the characteristic of the lesion, now known as Wickham striae. Further on, Darier explained the presence of such characteristic markings by correlating with an increase thickness of the granular cell layer. The coexistence of oral, cervical and stomach lichen planus lesions were described by Guogerot and Burnier in 1937. A similar variant of mucosal lichen planus as the vulvovaginal-gingival syndrome with erosive lesions involving oral and vulvovaginal mucosa were introduced by Pelisse and colleagues in year 1982.[2]

The origin of the word is believed to be from the Greek word ''Leichen'', which means tree moss, and also from Latin word ''planus'', which means flat and even surface.

Research

Apremilast is undergoing investigation as a potential treatment.[87]

Notes and References

  1. Wang EH, Monga I, Sallee BN, Chen JC, Abdelaziz AR, Perez-Lorenzo R, Bordone LA, Christiano AM. Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways . PNAS Nexus . 1 . 3 . pgac111 . Jul 2022 . 35899069 . 10.1093/pnasnexus/pgac111. 9308563 .
  2. Gorouhi F, Davari P, Fazel N . Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis . The Scientific World Journal . 2014 . 742826 . 2014-01-30 . 24672362 . 3929580 . 10.1155/2014/742826 . free.
  3. 2005-03-01. Inverse lichen planus: An unusual morphologic variant of a classic papulosquamous dermatosis . Journal of the American Academy of Dermatology. 52. 3. P64 . 10.1016/j.jaad.2004.10.268. 1097-6787. free.
  4. Book: Onalaja . Amanda A. . Taylor . Susan C. . Li . Becky S. . Maibach . Howard I. . Ethnic Skin and Hair and Other Cultural Considerations . 2021 . Springer . Switzerland . 978-3-030-64829-9 . https://books.google.com/books?id=_m4hEAAAQBAJ&dq=planus&pg=PA10 . en . 1. Defining skin color. 10.
  5. Meredith A. Olson . Roy S. Rogers III . Alison J. Bruce. 2016. Oral lichen planus. Clinics in Dermatology.
  6. Book: Greenberg MS, Glick M, Ship JA . Burket's oral medicine. 2008. BC Decker. Hamilton, Ont.. 9781550093452. 89–97. 11th.
  7. Book: Lewis MA, Jordan RC . Oral medicine. 2012. Manson Publishing. London. 9781840761818. 66–72. 2nd.
  8. Book: Barnes L . Surgical pathology of the head and neck. 2009. Informa healthcare. New York. 9781420091632. 3rd.
  9. Book: Limited, Therapeutic Guidelines. Therapeutic guidelines. 2009 . Therapeutic Guidelines . North Melbourne, Vic.. 978-0-9804764-3-9. 254–55, 302. Version 3..
  10. Le Cleach L, Chosidow O . Clinical practice. Lichen planus . The New England Journal of Medicine . 366 . 8 . 723–32 . February 2012 . 22356325 . 10.1056/NEJMcp1103641 .
  11. Asch S, Goldenberg G . Systemic treatment of cutaneous lichen planus: an update . Cutis . 87 . 3 . 129–34 . March 2011 . 21488570 .
  12. Sharma A, Białynicki-Birula R, Schwartz RA, Janniger CK . Lichen planus: an update and review . Cutis . 90 . 1 . 17–23 . July 2012 . 22908728 .
  13. Cheng S, Kirtschig G, Cooper S, Thornhill M, Leonardi-Bee J, Murphy R . Interventions for erosive lichen planus affecting mucosal sites . The Cochrane Database of Systematic Reviews . 2 . 2 . CD008092 . February 2012 . 22336835 . 10.1002/14651858.CD008092.pub2 . 1871/48562 .
  14. Book: Treister NS, Bruch JM . Clinical oral medicine and pathology. limited . 2010. Humana Press. New York. 978-1-60327-519-4. 59–62.
  15. Wagner G, Rose C, Sachse MM . Clinical variants of lichen planus . Journal der Deutschen Dermatologischen Gesellschaft . 11 . 4 . 309–19 . April 2013 . 23320493 . 10.1111/ddg.12031 . 8927462 .
  16. Gorouhi. F. Firooz A . Khatami A . Ladoyanni E . Bouzari N . Kamangar F . Gill JK . Interventions for cutaneous lichen planus . Cochrane Database of Systematic Reviews. 2009. 4. 10.1002/14651858.CD008038.
  17. Book: Bolognia . Jean L. . Dermatology . 2008 . Mosby/Elsevier . St. Louis . 978-1-4160-2999-1 . 2nd . Joseph L. . Jorizzo . Ronald P. . Rapini.
  18. Book: Andrews' Diseases of the skin : clinical dermatology. limited. Elston. Dirk M.. Berger. Timothy G. . vanc . Saunders/Elsevier. 978-1-4377-0314-6. 11th. London. 219–24. William D.. James. 2011.
  19. Book: Irwin M. . Freedberg . vanc . Fitzpatrick's dermatology in general medicine . 2003 . McGraw-Hill . New York, NY . 978-0-07-138076-8 . 366, 470–71 . 6th.
  20. Book: William D. . James . Dirk M. . Elston . Timothy G. . Berger . vanc . Andrews' Diseases of the skin : clinical dermatology . limited . Saunders/ Elsevier . London . 978-1-4377-0314-6 . 11th . 220. 2011 .
  21. Book: Irwin M. . Freedberg . vanc . Fitzpatrick's dermatology in general medicine . 2003 . McGraw-Hill . New York, NY . 978-0-07-138076-8 . 466 . 6th.
  22. Book: Irwin M. . Freedberg . vanc . Fitzpatrick's dermatology in general medicine . 2003 . McGraw-Hill . New York, NY . 978-0-07-138076-8 . 468 . 6th.
  23. Book: William D. . James . Dirk M. . Elston . Timothy G. . Berger . Andrews' Diseases of the skin : clinical dermatology . limited . Saunders/ Elsevier . London . 978-1-4377-0314-6 . 11th . 223. 2011 .
  24. Gordon KA, Vega JM, Tosti A . Trachyonychia: a comprehensive review . Indian Journal of Dermatology, Venereology and Leprology . 77 . 6 . 640–5 . Nov–Dec 2011 . 22016269 . 10.4103/0378-6323.86470 . free .
  25. Book: William D. . James . Dirk M. . Elston . Timothy G. . Berger . vanc . Andrews' Diseases of the skin : clinical dermatology . limited . Saunders/ Elsevier . London . 978-1-4377-0314-6 . 11th . 781. 2011 .
  26. Web site: Orphanet: Rare Diseases. Orphanet. June 3, 2016.
  27. Web site: Cicatricial Alopecia Research Foundation. www.carfintl.org. June 3, 2016.
  28. Book: Irwin M. . Freedberg . vanc . Fitzpatrick's dermatology in general medicine . 2003 . McGraw-Hill . New York, NY . 978-0-07-138076-8 . 471 . 6th.
  29. Book: Irwin M. . Freedberg . vanc . Fitzpatrick's dermatology in general medicine . 2003 . McGraw-Hill . New York, NY . 978-0-07-138076-8 . 472 . 6th.
  30. Book: William D. . James . Dirk M. . Elston . Timothy G. . Berger . vanc . Andrews' Diseases of the skin : clinical dermatology . limited . Saunders/ Elsevier . London . 978-1-4377-0314-6 . 11th . 224. 2011 .
  31. Book: Irwin M. . Freedberg . vanc . Fitzpatrick's dermatology in general medicine . 2003 . McGraw-Hill . New York, NY . 978-0-07-138076-8 . 473 . 6th.
  32. Book: William D. . James . Dirk M. . Elston . Timothy G. . Berger . vanc . Andrews' Diseases of the skin : clinical dermatology . limited . Saunders/ Elsevier . London . 978-1-4377-0314-6 . 11th . 639. 2011 .
  33. Ebrahimi M, Lundqvist L, Wahlin YB, Nylander E . 25165134 . Mucosal lichen planus, a systemic disease requiring multidisciplinary care: a cross-sectional clinical review from a multidisciplinary perspective . Journal of Lower Genital Tract Disease . 16 . 4 . 377–80 . October 2012 . 22622344 . 10.1097/LGT.0b013e318247a907 .
  34. Book: Yamada T, Alpers DH . Textbook of gastroenterology. limited . 2009. Blackwell Pub.. Chichester, West Sussex. 978-1-4051-6911-0. 5th. 3304. etal.
  35. Chandan VS, Murray JA, Abraham SC . Esophageal lichen planus . Archives of Pathology & Laboratory Medicine . 132 . 6 . 1026–9 . June 2008 . 18517264 . 10.5858/2008-132-1026-ELP .
  36. Panagiotopoulou N, Wong CS, Winter-Roach B . 45115301 . Vulvovaginal-gingival syndrome . Journal of Obstetrics and Gynaecology . 30 . 3 . 226–30 . April 2010 . 20373919 . 10.3109/01443610903477572 .
  37. Schlosser BJ . Lichen planus and lichenoid reactions of the oral mucosa . Dermatologic Therapy . 23 . 3 . 251–67 . May–Jun 2010 . 20597944 . 10.1111/j.1529-8019.2010.01322.x . 37730720 . free .
  38. Nico MM, Fernandes JD, Lourenço SV . Oral lichen planus . Anais Brasileiros de Dermatologia . 86 . 4 . 633–41; quiz 642–3 . Jul–Aug 2011 . 21987126 . 10.1590/s0365-05962011000400002 . free .
  39. Alam F, Hamburger J . Oral mucosal lichen planus in children . International Journal of Paediatric Dentistry . 11 . 3 . 209–14 . May 2001 . 11484471 . 10.1046/j.1365-263X.2001.00266.x .
  40. Farhi D, Dupin N . Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies . Clinics in Dermatology . 28 . 1 . 100–8 . 2010 . 20082959 . 10.1016/j.clindermatol.2009.03.004 .
  41. Lodi. Giovanni. Manfredi. Maddalena. Mercadante. Valeria . Murphy. Ruth. Carrozzo. Marco. 28 February 2020. Interventions for treating oral lichen planus: corticosteroid therapies. The Cochrane Database of Systematic Reviews. 2020. 2. CD001168. 10.1002/14651858.CD001168.pub3. 1469-493X. 7047223. 32108333.
  42. Book: Scully C. Oral and maxillofacial medicine : the basis of diagnosis and treatment. Churchill Livingstone. 2008. 9780702049484. 3rd. Edinburgh. 192–99.
  43. Web site: UpToDate. www.uptodate.com. 2019-01-04.
  44. Lehman JS, Tollefson MM, Gibson LE . Lichen planus . International Journal of Dermatology . 48 . 7 . 682–94 . July 2009 . 19570072 . 10.1111/j.1365-4632.2009.04062.x . 35881020 . free .
  45. McCartan BE . Psychological factors associated with oral lichen planus . Journal of Oral Pathology & Medicine . 24 . 6 . 273–5 . July 1995 . 7562664 . 10.1111/j.1600-0714.1995.tb01181.x .
  46. Eisen D . The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients . Journal of the American Academy of Dermatology . 46 . 2 . 207–14 . February 2002 . 11807431 . 10.1067/mjd.2002.120452 .
  47. Schlosser BJ . Lichen planus and lichenoid reactions of the oral mucosa . Dermatologic Therapy . 23 . 3 . 251–67 . May 2010 . 20597944 . 10.1111/j.1529-8019.2010.01322.x . 37730720 . free .
  48. Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A . Pathogenesis of oral lichen planus--a review . Journal of Oral Pathology & Medicine . 39 . 10 . 729–34 . November 2010 . 20923445 . 10.1111/j.1600-0714.2010.00946.x . 3384200 .
  49. Siponen M, Kauppila JH, Soini Y, Salo T . TLR4 and TLR9 are induced in oral lichen planus . Journal of Oral Pathology & Medicine . 41 . 10 . 741–7 . November 2012 . 22672741 . 10.1111/j.1600-0714.2012.01169.x .
  50. El Tawdy A, Rashed L . Downregulation of TLR-7 receptor in hepatic and non-hepatic patients with lichen planus . International Journal of Dermatology . 51 . 7 . 785–9 . July 2012 . 22715821 . 10.1111/j.1365-4632.2011.04977.x . 34765371 . free .
  51. Janardhanam SB, Prakasam S, Swaminathan VT, Kodumudi KN, Zunt SL, Srinivasan M . Differential expression of TLR-2 and TLR-4 in the epithelial cells in oral lichen planus . Archives of Oral Biology . 57 . 5 . 495–502 . May 2012 . 22119043 . 10.1016/j.archoralbio.2011.10.013 .
  52. Carrozzo M, Uboldi de Capei M, Dametto E, Fasano ME, Arduino P, Broccoletti R, Vezza D, Rendine S, Curtoni ES, Gandolfo S . Tumor necrosis factor-alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus . The Journal of Investigative Dermatology . 122 . 1 . 87–94 . January 2004 . 14962095 . 10.1046/j.0022-202X.2003.22108.x . free .
  53. Lallas. A.. Kyrgidis. A.. Tzellos. T. G.. Apalla. Z.. Karakyriou. E.. Karatolias. A.. Lefaki. I.. Sotiriou. E.. Ioannides. D.. June 2012. Accuracy of dermoscopic criteria for the diagnosis of psoriasis, dermatitis, lichen planus and pityriasis rosea. The British Journal of Dermatology. 166. 6. 1198–1205. 10.1111/j.1365-2133.2012.10868.x. 1365-2133. 22296226. 1468632.
  54. Friedman. Paula. Sabban. Emilia Cohen. Marcucci. Carolina. Peralta. Rosario. Cabo. Horacio. October 2015. Dermoscopic findings in different clinical variants of lichen planus. Is dermoscopy useful?. Dermatology Practical & Conceptual. 5. 4. 51–55. 10.5826/dpc.0504a13. 2160-9381. 4667604. 26693092.
  55. Agha R, Mirowski GW . The art and science of oral examination . Dermatologic Therapy . 23 . 3 . 209–19 . May 2010 . 20597940 . 10.1111/j.1529-8019.2010.01318.x . 6367644 .
  56. Eisen D . The oral mucosal punch biopsy. A report of 140 cases . Archives of Dermatology . 128 . 6 . 815–7 . June 1992 . 1599270 . 10.1001/archderm.1992.01680160099013 .
  57. Vargas-Díez E, García-Díez A, Marín A, Fernández-Herrera J . Life-threatening graft-vs-host disease . Clinics in Dermatology . 23 . 3 . 285–300 . May 2005 . 15896544 . 10.1016/j.clindermatol.2004.06.005 .
  58. Warnakulasuriya S, Johnson NW, van der Waal I . Nomenclature and classification of potentially malignant disorders of the oral mucosa . Journal of Oral Pathology & Medicine . 36 . 10 . 575–80 . November 2007 . 17944749 . 10.1111/j.1600-0714.2007.00582.x . free .
  59. van der Meij EH, Mast H, van der Waal I . The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients . Oral Oncology . 43 . 8 . 742–8 . September 2007 . 17112770 . 10.1016/j.oraloncology.2006.09.006 .
  60. Hietanen J, Paasonen MR, Kuhlefelt M, Malmström M . A retrospective study of oral lichen planus patients with concurrent or subsequent development of malignancy . Oral Oncology . 35 . 3 . 278–82 . May 1999 . 10621848 . 10.1016/S1368-8375(98)00116-X .
  61. Parashar P . Oral lichen planus . Otolaryngologic Clinics of North America . 44 . 1 . 89–107, vi . February 2011 . 21093625 . 10.1016/j.otc.2010.09.004 .
  62. Duncan SC, Su WP . Leukoedema of the oral mucosa. Possibly an acquired white sponge nevus . Archives of Dermatology . 116 . 8 . 906–8 . August 1980 . 7406518 . 10.1001/archderm.1980.01640320056014 .
  63. Martin JL . Leukoedema: a review of the literature . Journal of the National Medical Association . 84 . 11 . 938–40 . November 1992 . 1460680 . 2571748 .
  64. Shay K, Truhlar MR, Renner RP . Oropharyngeal candidosis in the older patient . Journal of the American Geriatrics Society . 45 . 7 . 863–70 . July 1997 . 9215341 . 10.1111/j.1532-5415.1997.tb01517.x . 2027.42/111172 . 46075976 . free .
  65. Majdy Idrees, Camile S Farah, Syed Ali Khurram, Norman Firth, Merva Soluk-Tekkesin, Omar Kujan. 2021, Observer agreement in the diagnosis of oral lichen planus using the proposed criteria of the American Academy of Oral and Maxillofacial Pathology. J Oral Pathol Med 2021 Mar 17. doi:10.1111/jop.13170
  66. Book: Oral and maxillofacial surgery. Oxford University Press. 2010. 978-0-19-920483-0. Kerawala C, Newlands C. Oxford. 412–13.
  67. Issa Y, Brunton PA, Glenny AM, Duxbury AJ . Healing of oral lichenoid lesions after replacing amalgam restorations: a systematic review . Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 98 . 5 . 553–65 . November 2004 . 15529127 . 10.1016/j.tripleo.2003.12.027 .
  68. Scully. C.. El-Kom, M. . Lichen planus: review and update on pathogenesis. Journal of Oral Pathology and Medicine. 1 July 1985. 14. 6. 431–58 . 10.1111/j.1600-0714.1985.tb00516.x. 3926971.
  69. Cribier B, Frances C, Chosidow O . Treatment of lichen planus. An evidence-based medicine analysis of efficacy . Archives of Dermatology . 134 . 12 . 1521–30 . December 1998 . 9875189 . 10.1001/archderm.134.12.1521 .
  70. Antiga E, Caproni M, Parodi A, Cianchini G, Fabbri P . Treatment of cutaneous lichen planus: an evidence based analysis of efficacy by the Italian Group for Cutaneous Immunopathology . Giornale Italiano di Dermatologia e Venereologia . 149 . 6 . 719–26 . December 2014 . 25664824 .
  71. Cheng S, Kirtschig G, Cooper S, Thornhill M, Leonardi-Bee J, Murphy R . Interventions for erosive lichen planus affecting mucosal sites . The Cochrane Database of Systematic Reviews . 2 . CD008092 . February 2012 . 22336835 . 10.1002/14651858.CD008092.pub2 . 1871/48562 . 10794897 .
  72. Web site: Tsu-Yi Chuang . Feb 24, 2020. Lichen Planus: Practice Essentials, Background, Pathophysiology .
  73. Idrees . M . Kujan . O . Shearston . K . Farah . CS . Oral lichen planus has a very low malignant transformation rate: A systematic review and meta-analysis using strict diagnostic and inclusion criteria. . Journal of Oral Pathology & Medicine . 25 January 2020 . 50 . 3 . 287–298 . 10.1111/jop.12996 . 31981238. 210891674 .
  74. Web site: UpToDate. www.uptodate.com. 2019-01-07.
  75. Miller CS, Epstein JB, Hall EH, Sirois D . Changing oral care needs in the United States: the continuing need for oral medicine . Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 91 . 1 . 34–44 . January 2001 . 11174569 . 10.1067/moe.2001.110439 .
  76. Bouquot JE, Gorlin RJ . Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years . Oral Surgery, Oral Medicine, and Oral Pathology . 61 . 4 . 373–81 . April 1986 . 3458148 . 10.1016/0030-4220(86)90422-6 .
  77. Axéll T, Rundquist L . Oral lichen planus--a demographic study . Community Dentistry and Oral Epidemiology . 15 . 1 . 52–6 . February 1987 . 3467894 . 10.1111/j.1600-0528.1987.tb00480.x .
  78. Alabi GO, Akinsanya JB . Lichen planus in tropical Africa . Tropical and Geographical Medicine . 33 . 2 . 143–7 . June 1981 . 7281214 .
  79. Li TJ, Cui J . COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma . Asian Pacific Journal of Tropical Medicine . 6 . 8 . 640–3 . August 2013 . 23790336 . 10.1016/s1995-7645(13)60110-8 . free .
  80. Yu TC, Kelly SC, Weinberg JM, Scheinfeld NS . Isolated lichen planus of the lower lip . Cutis . 71 . 3 . 210–2 . March 2003 . 12661749 .
  81. McCartan BE, Healy CM . The reported prevalence of oral lichen planus: a review and critique . Journal of Oral Pathology & Medicine . 37 . 8 . 447–53 . September 2008 . 18624932 . 10.1111/j.1600-0714.2008.00662.x .
  82. Carbone M, Arduino PG, Carrozzo M, Gandolfo S, Argiolas MR, Bertolusso G, Conrotto D, Pentenero M, Broccoletti R . Course of oral lichen planus: a retrospective study of 808 northern Italian patients . Oral Diseases . 15 . 3 . 235–43 . April 2009 . 19222766 . 10.1111/j.1601-0825.2009.01516.x .
  83. Hellgren L . The prevalence of rheumatoid arthritis in different geographical areas in Sweden . Acta Rheumatologica Scandinavica . 16 . 4 . 293–303 . December 1970 . 5493043 . 10.3109/rhe1.1970.16.issue-1-4.34 .
  84. Nagao T, Ikeda N, Fukano H, Hashimoto S, Shimozato K, Warnakulasuriya S . Incidence rates for oral leukoplakia and lichen planus in a Japanese population . Journal of Oral Pathology & Medicine . 34 . 9 . 532–9 . October 2005 . 16138891 . 10.1111/j.1600-0714.2005.00349.x .
  85. Xue JL, Fan MW, Wang SZ, Chen XM, Li Y, Wang L . A clinical study of 674 patients with oral lichen planus in China . Journal of Oral Pathology & Medicine . 34 . 8 . 467–72 . September 2005 . 16091113 . 10.1111/j.1600-0714.2005.00341.x .
  86. Thorn JJ, Holmstrup P, Rindum J, Pindborg JJ . Course of various clinical forms of oral lichen planus. A prospective follow-up study of 611 patients . Journal of Oral Pathology . 17 . 5 . 213–8 . May 1988 . 3144584 . 10.1111/j.1600-0714.1988.tb01527.x .
  87. Paul J, Foss CE, Hirano SA, Cunningham TD, Pariser DM . An open-label pilot study of apremilast for the treatment of moderate to severe lichen planus: a case series . Journal of the American Academy of Dermatology . 68 . 2 . 255–61 . February 2013 . 22910104 . 10.1016/j.jaad.2012.07.014 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Lichen planus".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.